Avacta Plans 2014 Launch of Custom Affimer Production Service, High-content Microarrays | GenomeWeb

British life sciences firm Avacta Group has begun commercialization of its affimer protein affinity reagents with the aim of launching by the end of this year a high-content microarray product and custom reagent services based on the molecules.

The company also this week announced a collaboration with Liverpool University researcher Rob Beynon on combining the affimer technology with mass spectrometry for biomarker and drug target discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.